MedPath

Edarbi

These HIGHLIGHTS do not include all the information needed to use EDARBI safely and effectively. See full prescribing information for EDARBI. Edarbi (azilsartan medoxomil) tablets, for oral use Initial U.S. Approval: 2011

Approved
Approval ID

52b27c75-9f5a-4816-bafd-dace9d7d2063

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 23, 2024

Manufacturers
FDA

Azurity Pharmaceuticals, Inc.

DUNS: 117505635

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azilsartan kamedoxomil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60631-040
Application NumberNDA200796
Product Classification
M
Marketing Category
C73594
G
Generic Name
Azilsartan kamedoxomil
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 29, 2024
FDA Product Classification

INGREDIENTS (8)

croscarmellose sodiumInactive
Code: M28OL1HH48
Classification: IACT
Azilsartan kamedoxomilActive
Quantity: 40 mg in 1 1
Code: WEC6I2K1FC
Classification: ACTIR
fumaric acidInactive
Code: 88XHZ13131
Classification: IACT
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

Azilsartan kamedoxomil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60631-080
Application NumberNDA200796
Product Classification
M
Marketing Category
C73594
G
Generic Name
Azilsartan kamedoxomil
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 29, 2024
FDA Product Classification

INGREDIENTS (8)

Azilsartan kamedoxomilActive
Quantity: 80 mg in 1 1
Code: WEC6I2K1FC
Classification: ACTIR
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
fumaric acidInactive
Code: 88XHZ13131
Classification: IACT
croscarmellose sodiumInactive
Code: M28OL1HH48
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Edarbi - FDA Drug Approval Details